We are live on ! Find out more
LP

LMR Partners Portfolio holdings

AUM $45.4B
1-Year Est. Return 60.68%
This Fund
S&P 500
This Quarter Est. Return
+1.72%
1 Year Est. Return
+60.68%
3 Year Est. Return
+183.94%
5 Year Est. Return
+215.13%
10 Year Est. Return
+663.15%
AUM
$8.9B
AUM Growth
-$114M
Cap. Flow
-$576M
Cap. Flow %
-6.48%
Top 10 Hldgs %
30.36%
Holding
1,130
New
262
Increased
147
Reduced
90
Closed
203

Sector Composition

Rank Sector Weight
1 Technology 10.2%
2 Financials 6.08%
3 Healthcare 4.77%
4 Energy 4.31%
5 Utilities 3.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LVOXW
451
DELISTED
LiveVox Holding, Inc. Warrant
LVOXW
$968K 0.01%
3,456,658
+128,394
+4% +$38.4K
FLNA
452
PUT
Filana Therapeutics
FLNA
$43.5M
$965K 0.01%
58,000
+28,400
+96% +$563K
BYND icon
453
PUT
Beyond Meat
BYND
$283M
$962K 0.01%
+100,000
New +$1.3M
NTLA icon
454
Intellia Therapeutics
NTLA
$1.49B
$958K 0.01%
30,290
+11,600
+62% +$450K
SHOP icon
455
Shopify
SHOP
$165B
$950K 0.01%
17,410
LLAP.WS
456
DELISTED
Terran Orbital Corporation Redeemable Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50
LLAP.WS
$949K 0.01%
6,328,206
MUFG icon
457
Mitsubishi UFJ Financial
MUFG
$260B
$941K 0.01%
+110,834
New +$884K
TMTC
458
DELISTED
TMT Acquisition Corp Ordinary Shares
TMTC
$940K 0.01%
+90,000
New +$933K
IOT icon
459
Samsara
IOT
$20.6B
$922K 0.01%
+36,569
New +$970K
GGROW
460
Gogoro Inc Warrant
GGROW
$205K
$919K 0.01%
4,834,590
+228,678
+5% +$59K
TAL icon
461
TAL Education Group
TAL
$5.86B
$911K 0.01%
+100,000
New +$701K
NVAX icon
462
CALL
Novavax
NVAX
$1.23B
$886K 0.01%
+122,400
New +$978K
WBX.WS
463
DELISTED
Wallbox N.V. Warrants, each warrant to purchase one Class A Ordinary Share
WBX.WS
$878K 0.01%
2,143,607
GRCL
464
DELISTED
Gracell Biotechnologies Inc. American Depositary Shares
GRCL
$874K 0.01%
484,516
+314,482
+185% +$1.15M
KROS icon
465
Keros Therapeutics
KROS
$202M
$869K 0.01%
27,245
EVGOW
466
DELISTED
EVgo Inc Warrants
EVGOW
$862K 0.01%
2,393,325
XENE icon
467
Xenon Pharmaceuticals
XENE
$6.36B
$854K 0.01%
+25,000
New +$935K
P
468
Everpure Inc
P
$24.7B
$833K 0.01%
+23,382
New +$867K
SCHW
469
Charles Schwab
SCHW
$181B
$818K 0.01%
+14,904
New +$901K
APLS
470
PUT
DELISTED
Apellis Pharmaceuticals
APLS
$810K 0.01%
+21,300
New +$936K
NVCR icon
471
PUT
NovoCure
NVCR
$1.97B
$808K 0.01%
+50,000
New +$1.44M
ONTO icon
472
Onto Innovation
ONTO
$13B
$807K 0.01%
+6,331
New +$753K
RDW.WS
473
DELISTED
Redwire Corporation Redeemable Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share
RDW.WS
$805K 0.01%
1,828,985
+716,307
+64% +$374K
AMC icon
474
CALL
AMC Entertainment Holdings
AMC
$2.24B
$799K 0.01%
100,000
+99,910
+111,011% +$2.96M
CPA icon
475
Copa Holdings
CPA
$5.65B
$772K 0.01%
8,662

Similar funds

LMR Partners's Q3 2023 Portfolio in Review

As of Q3 2023, LMR Partners held 1,130 positions worth $8.9B, down 1.3% from $9.01B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

LMR Partners withdrew a net $576M in Q3 2023, closing 203 positions and reducing 90 holdings. Its most notable exit was IVERIC bio, Inc. Common Stock, an estimated $79.6M position sold in full.

By sector, the portfolio is most concentrated in Technology at 10% of assets, up from 7.7% a quarter earlier, followed by Financials and Healthcare.

Against the trend, LMR Partners opened a new position in Invesco QQQ Trust worth $174M.

  • LMR Partners's largest Q3 2023 buy was Invesco QQQ Trust: 486,109 shares worth $174M.
  • LMR Partners added most to Activision Blizzard in Q3 2023, an estimated $63.6M increase.
  • LMR Partners's biggest Q3 2023 reduction was LPL Financial, cutting an estimated $71.1M.
  • LMR Partners fully exited IVERIC bio, Inc. Common Stock in Q3 2023, selling an estimated $79.6M.
  • LMR Partners's ten largest holdings make up 30% of its $8.9B portfolio in Q3 2023.
  • LMR Partners opened 262 new positions and closed 203 in Q3 2023.
  • LMR Partners's portfolio value fell 1.3% quarter-over-quarter to $8.9B.

Based on LMR Partners's 13F filing for Q3 2023, filed 14 Nov 2023.